BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10910743)

  • 1. Contemporary models for peripheral tolerance and the classical 'historical postulate'.
    Bretscher P
    Semin Immunol; 2000 Jun; 12(3):221-9; discussion 257-344. PubMed ID: 10910743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danger: the view from the bottom of the cliff.
    Anderson CC; Matzinger P
    Semin Immunol; 2000 Jun; 12(3):231-8; discussion 257-344. PubMed ID: 10910744
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-help in T cell recognition?
    Bakker TR; van der Merwe PA
    Nat Immunol; 2002 Jan; 3(1):11-2. PubMed ID: 11753401
    [No Abstract]   [Full Text] [Related]  

  • 4. Costimulation and endogenous MHC ligands contribute to T cell recognition.
    Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
    Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The historical postulate: Is it the basis, at the level of the system, for self-nonself discrimination?
    Bretscher PA
    Scand J Immunol; 2021 Aug; 94(2):e13033. PubMed ID: 33624328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell.
    Patel DM; Mannie MD
    Cell Immunol; 2001 Dec; 214(2):165-72. PubMed ID: 12088415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
    van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
    Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does the immune system distinguish self from nonself?
    Medzhitov R; Janeway CA
    Semin Immunol; 2000 Jun; 12(3):185-8; discussion 257-344. PubMed ID: 10910738
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-presentation in viral immunity and self-tolerance.
    Heath WR; Carbone FR
    Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
    Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
    Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells.
    Aschenbrenner K; D'Cruz LM; Vollmann EH; Hinterberger M; Emmerich J; Swee LK; Rolink A; Klein L
    Nat Immunol; 2007 Apr; 8(4):351-8. PubMed ID: 17322887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-tolerance of natural killer cells.
    Raulet DH; Vance RE
    Nat Rev Immunol; 2006 Jul; 6(7):520-31. PubMed ID: 16799471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation: comments on its regulation and mechanism.
    Unanue ER; Beller DI; Lu CY; Allen PM
    J Immunol; 1984 Jan; 132(1):1-5. PubMed ID: 6228574
    [No Abstract]   [Full Text] [Related]  

  • 14. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.
    Gavin MA; Clarke SR; Negrou E; Gallegos A; Rudensky A
    Nat Immunol; 2002 Jan; 3(1):33-41. PubMed ID: 11740498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of T cell activation threshold tuning.
    van den Berg HA; Rand DA
    J Theor Biol; 2004 Jun; 228(3):397-416. PubMed ID: 15135038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic CD4+ T cell-targeted antigen-presenting cells elicit protective antitumor responses.
    Caserta S; Alessi P; Guarnerio J; Basso V; Mondino A
    Cancer Res; 2008 Apr; 68(8):3010-8. PubMed ID: 18413771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-step, two-signal model for the primary activation of precursor helper T cells.
    Bretscher PA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):185-90. PubMed ID: 9874793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local development of effector and memory T helper cells.
    Fazilleau N; McHeyzer-Williams LJ; McHeyzer-Williams MG
    Curr Opin Immunol; 2007 Jun; 19(3):259-67. PubMed ID: 17420119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning to be tolerant: how T cells keep out of trouble.
    Holländer GA; Peterson P
    J Intern Med; 2009 May; 265(5):541-61. PubMed ID: 19382993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.